Clinical Trials List
Protocol NumberGNX-001
Completed
2020-08-01 - 2024-11-29
Phase I
Terminated2
-
Trial Applicant
Linical
-
Sponsor
-
Trial scale
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 留奕廷 Division of Hematology & Oncology
- 趙盈瑞 Division of General Surgery
- Wen-Pin Su Division of Hematology & Oncology
- Yan-Shen Shan Division of General Surgery
- Yu-Min Yeh Division of Hematology & Oncology
- Shang-Yin Wu Division of Hematology & Oncology
- 楊舜如 Division of Hematology & Oncology
- Wei-Pang Chung Division of Hematology & Oncology
- Chien-Jui Huang Digestive System Department
- 劉奕廷 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ching-Chan Lin Division of Hematology & Oncology
- Chen-Yuan Lin Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Chang-Fang Chiu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
60 participants
